Tracy Zimmermann
Net worth: - $ as of 31/10/2026
Net worth: - $ as of 31/10/2026
Tracy Zimmermann is Chief Scientific Officer at City Therapeutics, Inc. since 2024.
Formerly, Dr. Zimmermann was Chief Development Officer at Generation Bio Co. from 2020 to 2024 and Senior Director-Research at Alnylam Pharmaceuticals, Inc. from 2012 to 2018.
Education includes undergraduate studies at Lehigh University and a doctorate from the University of Colorado Boulder.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
-.--% | 16/10/2026 | 0 ( -.--% ) | - $ | 31/10/2026 |
| Companies | Position | Start |
|---|
| Companies | Position | End |
|---|---|---|
| GENERATION BIO CO. | Corporate Officer/Principal | 28/01/2024 |
| ALNYLAM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/09/2018 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Lehigh University
Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Colorado Boulder
University of Colorado Boulder Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Generation Bio Co.
Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines | Health Technology |
Select your edition
All financial news and data tailored to specific country editions